China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong
· Delayed Price · Currency is HKD 5.22
-0.02 (-0.38%)
Mar 28, 2025, 4:08 PM HKT
HKG:3320 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 257,673 | 244,704 | 218,183 | 236,806 | 200,423 | Upgrade
|
| Revenue Growth (YoY) | 5.30% | 12.16% | -7.86% | 18.15% | -1.97% | Upgrade
|
| Cost of Revenue | 216,984 | 206,366 | 184,564 | 201,426 | 168,129 | Upgrade
|
| Gross Profit | 40,689 | 38,337 | 33,619 | 35,380 | 32,294 | Upgrade
|
| Selling, General & Admin | 26,557 | 25,252 | 21,999 | 23,792 | 21,611 | Upgrade
|
| Other Operating Expenses | 2,148 | 2,044 | 1,878 | 1,745 | 1,347 | Upgrade
|
| Operating Expenses | 28,705 | 27,296 | 23,878 | 25,537 | 22,958 | Upgrade
|
| Operating Income | 11,984 | 11,041 | 9,741 | 9,843 | 9,335 | Upgrade
|
| Interest Expense | -2,262 | -2,363 | -2,428 | -2,711 | -3,135 | Upgrade
|
| Interest & Investment Income | 681.1 | 587.69 | 721.18 | 731.55 | 680.18 | Upgrade
|
| Earnings From Equity Investments | 368.01 | 417.11 | 332.34 | 313.6 | 206.85 | Upgrade
|
| Other Non Operating Income (Expenses) | 1,007 | 1,057 | 181.76 | 353.5 | 559.3 | Upgrade
|
| EBT Excluding Unusual Items | 11,778 | 10,741 | 8,549 | 8,531 | 7,647 | Upgrade
|
| Merger & Restructuring Charges | - | -9.98 | - | -8.61 | -1.34 | Upgrade
|
| Impairment of Goodwill | -92.23 | -82.81 | -85.14 | -123.75 | -588.14 | Upgrade
|
| Gain (Loss) on Sale of Investments | -720.41 | -220.69 | -166.16 | 124.79 | 107.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | 70.12 | 63.85 | 334.84 | 9.61 | -17.85 | Upgrade
|
| Asset Writedown | -178.87 | -611.12 | -271.11 | -141.68 | -90.29 | Upgrade
|
| Other Unusual Items | 73.27 | - | - | 17.46 | 18.09 | Upgrade
|
| Pretax Income | 10,930 | 9,880 | 8,361 | 8,408 | 7,076 | Upgrade
|
| Income Tax Expense | 2,527 | 2,105 | 1,703 | 1,761 | 1,752 | Upgrade
|
| Earnings From Continuing Operations | 8,403 | 7,775 | 6,658 | 6,647 | 5,324 | Upgrade
|
| Minority Interest in Earnings | -5,052 | -3,921 | -3,158 | -2,879 | -2,027 | Upgrade
|
| Net Income | 3,351 | 3,854 | 3,500 | 3,769 | 3,297 | Upgrade
|
| Preferred Dividends & Other Adjustments | 19.59 | - | - | - | - | Upgrade
|
| Net Income to Common | 3,331 | 3,854 | 3,500 | 3,769 | 3,297 | Upgrade
|
| Net Income Growth | -13.06% | 10.11% | -7.13% | 14.31% | 0.33% | Upgrade
|
| Shares Outstanding (Basic) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | Upgrade
|
| Shares Outstanding (Diluted) | 6,283 | 6,283 | 6,283 | 6,283 | 6,283 | Upgrade
|
| Shares Change (YoY) | - | - | - | -0.01% | -0.02% | Upgrade
|
| EPS (Basic) | 0.53 | 0.61 | 0.56 | 0.60 | 0.52 | Upgrade
|
| EPS (Diluted) | 0.53 | 0.61 | 0.56 | 0.60 | 0.52 | Upgrade
|
| EPS Growth | -13.57% | 10.11% | -7.13% | 14.32% | 0.35% | Upgrade
|
| Free Cash Flow | - | 13,027 | 8,542 | 10,428 | 6,537 | Upgrade
|
| Free Cash Flow Per Share | - | 2.07 | 1.36 | 1.66 | 1.04 | Upgrade
|
| Dividend Per Share | 0.135 | 0.154 | 0.142 | 0.150 | 0.120 | Upgrade
|
| Dividend Growth | -12.34% | 8.81% | -5.65% | 25.00% | 9.09% | Upgrade
|
| Gross Margin | 15.79% | 15.67% | 15.41% | 14.94% | 16.11% | Upgrade
|
| Operating Margin | 4.65% | 4.51% | 4.46% | 4.16% | 4.66% | Upgrade
|
| Profit Margin | 1.29% | 1.57% | 1.60% | 1.59% | 1.65% | Upgrade
|
| Free Cash Flow Margin | - | 5.32% | 3.91% | 4.40% | 3.26% | Upgrade
|
| EBITDA | 14,522 | 13,580 | 11,688 | 11,946 | 11,079 | Upgrade
|
| EBITDA Margin | 5.64% | 5.55% | 5.36% | 5.04% | 5.53% | Upgrade
|
| D&A For EBITDA | 2,539 | 2,539 | 1,947 | 2,103 | 1,744 | Upgrade
|
| EBIT | 11,984 | 11,041 | 9,741 | 9,843 | 9,335 | Upgrade
|
| EBIT Margin | 4.65% | 4.51% | 4.46% | 4.16% | 4.66% | Upgrade
|
| Effective Tax Rate | 23.12% | 21.31% | 20.37% | 20.94% | 24.76% | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.